Clarity Pharmaceuticals Ltd.ASX: CU6

Theranostic prostate cancer trial advances to cohort 3

Aug 10, 2023 at 3:08 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment